NCT07426913

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-05-20Est. Completion: 2026-07-30

Enrollment target: 30 participants

Locations

Adult Outpatient Pavilion, Richmond, Virginia, United States
Cellular Immunotherapies and Transplant Department, Richmond, Virginia, United States
VCU Health at Stony Point, Richmond, Virginia, United States

Contact

Early Breast Cancer

This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant g…

Daphne, United StatesEst. completion Aug 8, 2025

Breast CancerSolid Tumor

This is an open-label, multicenter, Phase I study designed to evaluate the safety, tolerability, and pharmacokinetics of…

Boston, United StatesEst. completion Dec 31, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.